FI942597A0 - 2-O-alkyyliaskorbiinihapon litiumsuola - Google Patents

2-O-alkyyliaskorbiinihapon litiumsuola

Info

Publication number
FI942597A0
FI942597A0 FI942597A FI942597A FI942597A0 FI 942597 A0 FI942597 A0 FI 942597A0 FI 942597 A FI942597 A FI 942597A FI 942597 A FI942597 A FI 942597A FI 942597 A0 FI942597 A0 FI 942597A0
Authority
FI
Finland
Prior art keywords
ascorbic acid
lithium salt
alkyl ascorbic
alkyl
lithium
Prior art date
Application number
FI942597A
Other languages
English (en)
Swedish (sv)
Other versions
FI942597A (fi
Inventor
Tadakazu Shimizu
Tatsuhiko Kaneko
Original Assignee
Tsumura & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tsumura & Co filed Critical Tsumura & Co
Publication of FI942597A publication Critical patent/FI942597A/fi
Publication of FI942597A0 publication Critical patent/FI942597A0/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/62—Three oxygen atoms, e.g. ascorbic acid

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FI942597A 1992-10-02 1994-06-02 2-O-alkyyliaskorbiinihapon litiumsuola FI942597A0 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP26469692 1992-10-02
PCT/JP1993/001409 WO1994007883A1 (en) 1992-10-02 1993-10-01 Lithium salt of 2-o-alkylascorbic acid

Publications (2)

Publication Number Publication Date
FI942597A FI942597A (fi) 1994-06-02
FI942597A0 true FI942597A0 (fi) 1994-06-02

Family

ID=17406923

Family Applications (1)

Application Number Title Priority Date Filing Date
FI942597A FI942597A0 (fi) 1992-10-02 1994-06-02 2-O-alkyyliaskorbiinihapon litiumsuola

Country Status (6)

Country Link
EP (1) EP0619313A4 (fi)
CN (1) CN1093360A (fi)
AU (1) AU4834793A (fi)
CA (1) CA2124340A1 (fi)
FI (1) FI942597A0 (fi)
WO (1) WO1994007883A1 (fi)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20060008913A (ko) * 2003-04-21 2006-01-27 타그라 바이오테크놀로지스 리미티드 아스코르브산의 안정화된 유도체
DK2564843T3 (en) 2005-06-01 2019-03-11 Bioelectron Tech Corp Redox-active therapeutics for the treatment of mitochondrial diseases and other conditions as well as modulation of energy biomarkers
PL1933821T3 (pl) 2005-09-15 2021-01-11 Ptc Therapeutics, Inc. Warianty łańcucha końcowego środków terapeutycznych o aktywności redoks do leczenia chorób mitochondrialnych i innych stanów oraz do modulacji biomarkerów energetycznych
JP5374162B2 (ja) 2006-02-22 2013-12-25 エジソン ファーマシューティカルズ， インコーポレイテッド ミトコンドリア病および他の症状の処置のためのレドックス活性化治療の側鎖変異体およびエネルギーバイオマーカーの調節
US8314153B2 (en) 2008-09-10 2012-11-20 Edison Pharmaceuticals, Inc. Treatment of pervasive developmental disorders with redox-active therapeutics
CN103896891A (zh) * 2014-03-25 2014-07-02 李玉成 抗坏血酸锂及其制备方法
CN108712903A (zh) 2015-12-17 2018-10-26 生物电子技术有限公司 用于治疗氧化应急障碍的氟烷基、氟代烷氧基、苯氧基、杂芳氧基、烷氧基和胺1,4-苯醌衍生物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4959362A (en) * 1983-12-19 1990-09-25 Takeda Chemical Industries, Inc. Pharmaceutical compositions containing certain ascorbic acid derivatives useful in the prophylaxis and treatment of disorders of the circulatory system
JPH0667834B2 (ja) * 1989-03-09 1994-08-31 二郎 藤本 抗腫瘍剤

Also Published As

Publication number Publication date
FI942597A (fi) 1994-06-02
CN1093360A (zh) 1994-10-12
WO1994007883A1 (en) 1994-04-14
EP0619313A1 (en) 1994-10-12
EP0619313A4 (en) 1995-02-15
AU4834793A (en) 1994-04-26
CA2124340A1 (en) 1994-04-14

Similar Documents

Publication Publication Date Title
DK480286A (da) Acrylsyreamider
MX9203539A (es) Amidas ramificadas de peptidos de l-aspartil-d-aminoacido y composiciones de las mismas.
BR9510256A (pt) Derivados de ácido 3-aril-tetrônico
ATE257836T1 (de) Salz von naphthyridincarbonsäure-derivaten
BR9301626A (pt) Derivado de acido picolinico e composicao herbicida
DE3162660D1 (de) Amides of 4-oxo-5-amidohexanoic acid derivatives
NO930760D0 (no) Substituerte fenyleddiksyreamider
DE59306063D1 (de) Hautkonditionierende bernsteinsäure-derivate
DK0623580T3 (da) 2-Keto-3-methyl-4-hydroxy-valerianesyre
NO173447C (no) Syreaddisjonssalt og anvendelse derav
DE59305938D1 (de) Pyridyloxy-acrylsäureester
NO930722L (no) Imidazolylsubstituerte fenyleddiksyreamider
FI942597A0 (fi) 2-O-alkyyliaskorbiinihapon litiumsuola
KR960700242A (ko) 8-메톡시퀴놀론카르복실산 유도체(8-methoxyquinolonecarboxylic acid derivative)
DE59307031D1 (de) Quaternierte fettsäure-triethanolaminester-salze
DE3478024D1 (de) Amides of 2-phenoxypropionic acid
DE69618045D1 (de) Clavulansäure Salz
DE69317893D1 (de) Percarbonsäure
DE69024193D1 (de) Ascorbinsäure-derivate
NO961783L (no) 5-arylisoxazol-4-yl-substituerte 2-aminokarboksylsyreforbindelser
FI961520A (fi) Heribisidiset atsabisfosfonihappoyhdisteet
DK514188A (da) Acrylsyrederivater
NO942013D0 (no) Litiumsalt av 2-0-alkylaskorbinsyre
DK161989A (da) Acrylsyrederivater
DK318085A (da) Nitroapovincaminsyrederivater

Legal Events

Date Code Title Description
FD Application lapsed